374 related articles for article (PubMed ID: 30813247)
1. Recombinant Glycoprotein E of Varicella Zoster Virus Contains Glycan-Peptide Motifs That Modulate B Cell Epitopes into Discrete Immunological Signatures.
Nordén R; Nilsson J; Samuelsson E; Risinger C; Sihlbom C; Blixt O; Larson G; Olofsson S; Bergström T
Int J Mol Sci; 2019 Feb; 20(4):. PubMed ID: 30813247
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of glycoprotein E subunit and live attenuated varicella-zoster virus vaccines formulated with a single-strand RNA-based adjuvant.
Lee SJ; Park HJ; Ko HL; Lee JE; Lee HJ; Kim H; Nam JH
Immun Inflamm Dis; 2020 Jun; 8(2):216-227. PubMed ID: 32167678
[TBL] [Abstract][Full Text] [Related]
3. Identification of immunodominant regions and linear B cell epitopes of the gE envelope protein of varicella-zoster virus.
Fowler WJ; Garcia-Valcarcel M; Hill-Perkins MS; Murphy G; Harper DR; Jeffries DJ; Burns NR; Adams SE; Kingsman AJ; Layton GT
Virology; 1995 Dec; 214(2):531-40. PubMed ID: 8553555
[TBL] [Abstract][Full Text] [Related]
4. Identification and Characterization of CD4
Voic H; de Vries RD; Sidney J; Rubiro P; Moore E; Phillips E; Mallal S; Schwan B; Weiskopf D; Sette A; Grifoni A
J Virol; 2020 Nov; 94(24):. PubMed ID: 32999027
[TBL] [Abstract][Full Text] [Related]
5. Induction of neutralizing antibody and T-cell responses to varicella-zoster virus (VZV) using Ty-virus-like particles carrying fragments of glycoprotein E (gE).
Garcia-Valcarcel M; Fowler WJ; Harper DR; Jeffries DJ; Layton GT
Vaccine; 1997; 15(6-7):709-19. PubMed ID: 9178473
[TBL] [Abstract][Full Text] [Related]
6. Immunogenicity in Mice Immunized with Recombinant Adenoviruses Expressing Varicella-Zoster Virus Envelope Glycoprotein E.
Zheng Y; Huang L; Ding H; Xu H; Shu R; Yu J; Peng X; Fu Y; He J
Viruses; 2023 Nov; 15(12):. PubMed ID: 38140528
[TBL] [Abstract][Full Text] [Related]
7. Recombinant glycoprotein E produced in mammalian cells in large-scale as an antigen for varicella-zoster-virus serology.
Thomsson E; Persson L; Grahn A; Snäll J; Ekblad M; Brunhage E; Svensson F; Jern C; Hansson GC; Bäckström M; Bergström T
J Virol Methods; 2011 Jul; 175(1):53-9. PubMed ID: 21540058
[TBL] [Abstract][Full Text] [Related]
8. Glycan Profiles of gp120 Protein Vaccines from Four Major HIV-1 Subtypes Produced from Different Host Cell Lines under Non-GMP or GMP Conditions.
Wang S; Voronin Y; Zhao P; Ishihara M; Mehta N; Porterfield M; Chen Y; Bartley C; Hu G; Han D; Wells L; Tiemeyer M; Lu S
J Virol; 2020 Mar; 94(7):. PubMed ID: 31941770
[TBL] [Abstract][Full Text] [Related]
9. Early steps in O-linked glycosylation and clustered O-linked glycans of herpes simplex virus type 1 glycoprotein C: effects on glycoprotein properties.
Biller M; Mårdberg K; Hassan H; Clausen H; Bolmstedt A; Bergström T; Olofsson S
Glycobiology; 2000 Dec; 10(12):1259-69. PubMed ID: 11159917
[TBL] [Abstract][Full Text] [Related]
10. LNP-CpG ODN-adjuvanted varicella-zoster virus glycoprotein E induced comparable levels of immunity with Shingrix™ in VZV-primed mice.
Luan N; Cao H; Wang Y; Lin K; Liu C
Virol Sin; 2022 Oct; 37(5):731-739. PubMed ID: 35671982
[TBL] [Abstract][Full Text] [Related]
11. Purification, characterization and immunogenicity of recombinant varicella-zoster virus glycoprotein gE secreted by Chinese hamster ovary cells.
Haumont M; Jacquet A; Massaer M; Deleersnyder V; Mazzu P; Bollen A; Jacobs P
Virus Res; 1996 Feb; 40(2):199-204. PubMed ID: 8725116
[TBL] [Abstract][Full Text] [Related]
12. Immunogenicity of a recombinant varicella-zoster virus gE-IE63 fusion protein, a putative vaccine candidate against primary infection and zoster reactivation.
Jacquet A; Haumont M; Massaer M; Garcia L; Mazzu P; Daminet V; Grégoire D; Jacobs P; Bollen A
Vaccine; 2002 Feb; 20(11-12):1593-602. PubMed ID: 11858867
[TBL] [Abstract][Full Text] [Related]
13. Sialic Acids on Varicella-Zoster Virus Glycoprotein B Are Required for Cell-Cell Fusion.
Suenaga T; Matsumoto M; Arisawa F; Kohyama M; Hirayasu K; Mori Y; Arase H
J Biol Chem; 2015 Aug; 290(32):19833-43. PubMed ID: 26105052
[TBL] [Abstract][Full Text] [Related]
14. Immunogenicity generated by mRNA vaccine encoding VZV gE antigen is comparable to adjuvanted subunit vaccine and better than live attenuated vaccine in nonhuman primates.
Monslow MA; Elbashir S; Sullivan NL; Thiriot DS; Ahl P; Smith J; Miller E; Cook J; Cosmi S; Thoryk E; Citron M; Thambi N; Shaw C; Hazuda D; Vora KA
Vaccine; 2020 Aug; 38(36):5793-5802. PubMed ID: 32703745
[TBL] [Abstract][Full Text] [Related]
15. Antibody-binding sites on truncated forms of varicella-zoster virus gpI(gE) glycoprotein.
Vafai A
Vaccine; 1994 Nov; 12(14):1265-9. PubMed ID: 7531921
[TBL] [Abstract][Full Text] [Related]
16. A study on enhanced O-glycosylation strategy for improved production of recombinant human chorionic gonadotropin in Chinese hamster ovary cells.
Deng Z; Yi X; Chu J; Zhuang Y
J Biotechnol; 2019 Dec; 306():159-168. PubMed ID: 31604106
[TBL] [Abstract][Full Text] [Related]
17. Culture media optimization for Chinese hamster ovary cell growth and expression of recombinant varicella-zoster virus glycoprotein E.
Kim KS; Park SA; Wui SR; Ko A; Lee NG
Cytotechnology; 2021 Jun; 73(3):433-445. PubMed ID: 33897103
[TBL] [Abstract][Full Text] [Related]
18. A highly conserved epitope-vaccine candidate against varicella-zoster virus induces neutralizing antibodies in mice.
Zhu R; Liu J; Chen C; Ye X; Xu L; Wang W; Zhao Q; Zhu H; Cheng T; Xia N
Vaccine; 2016 Mar; 34(13):1589-1596. PubMed ID: 26873057
[TBL] [Abstract][Full Text] [Related]
19. Cell-mediated immune responses to a varicella-zoster virus glycoprotein E vaccine using both a TLR agonist and QS21 in mice.
Dendouga N; Fochesato M; Lockman L; Mossman S; Giannini SL
Vaccine; 2012 Apr; 30(20):3126-35. PubMed ID: 22326899
[TBL] [Abstract][Full Text] [Related]
20. Site occupancy and glycan compositional analysis of two soluble recombinant forms of the attachment glycoprotein of Hendra virus.
Colgrave ML; Snelling HJ; Shiell BJ; Feng YR; Chan YP; Bossart KN; Xu K; Nikolov DB; Broder CC; Michalski WP
Glycobiology; 2012 Apr; 22(4):572-84. PubMed ID: 22171062
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
